Chang‐Jun Tan
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Hepatology 13
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Liver physiology and pathology 4
- Oncology 11
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Jia Fan (17 shared papers)Jian Zhou (13 shared papers)Jian Zhou (7 shared papers)Xiao‐Dong Zhu (8 shared papers)Hui‐Chuan Sun (8 shared papers)Cheng Huang (7 shared papers)Ying‐Hao Shen (8 shared papers)Ningling Ge (5 shared papers)
In The Last Decade
Chang‐Jun Tan
26 papers receiving 698 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Hepatology 338
- Cancer Research 168
- Transplantation 25
- Oncology 180
- Pathology and Forensic Medicine 109
Countries citing papers authored by Chang‐Jun Tan
This map shows the geographic impact of Chang‐Jun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Jun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Jun Tan more than expected).
Fields of papers citing papers by Chang‐Jun Tan
This network shows the impact of papers produced by Chang‐Jun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Jun Tan. The network helps show where Chang‐Jun Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang‐Jun Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations Hit paper breakdown → | 2021 | 159 |
| 2 | 2008 | 77 | |
| 3 | 2013 | 58 | |
| 4 | 2012 | 50 | |
| 5 | 2021 | 48 | |
| 6 | 2008 | 46 | |
| 7 | 2014 | 43 | |
| 8 | 2008 | 30 | |
| 9 | 2015 | 28 | |
| 10 | Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. | 2006 | 23 |
| 11 | 2009 | 21 | |
| 12 | 2007 | 20 | |
| 13 | 2013 | 18 | |
| 14 | 2020 | 13 | |
| 15 | 2011 | 11 | |
| 16 | 2012 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 8 | |
| 19 | 2014 | 8 | |
| 20 | 2020 | 8 |
About Chang‐Jun Tan
Chang‐Jun Tan is a scholar working on Hepatology, Oncology, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 706 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (6 papers), Liver physiology and pathology (4 papers), Ferroptosis and cancer prognosis (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Cancer, Lipids, and Metabolism (3 papers), Transplantation: Methods and Outcomes (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Hepatology (338 citations), Cancer Research (168 citations), Transplantation (25 citations), Oncology (180 citations) and Pathology and Forensic Medicine (109 citations). Chang‐Jun Tan has collaborated with scholars based in China, Norway and Germany. Frequent co-authors include Jia Fan, Jian Zhou, Jian Zhou, Xiao‐Dong Zhu, Hui‐Chuan Sun, Cheng Huang, Ying‐Hao Shen, Ningling Ge, Zhao–You Tang and Yuan Ji. Their work appears in journals such as Journal of Clinical Oncology, Expert Opinion on Investigational Drugs, Biomarker Research, Electrophoresis and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.